Baird Downgrades Regeneron Pharma (REGN) to Neutral

Regeneron (REGN) Climbs Following Upgarde

Regeneron (NASDAQ: REGN) climbed Thursday, adding to recent gains, after it was upgraded at Barclays to Overweight. Shares were up 4.15%.

Piper Sandler Reiterates Overweight Rating on Regeneron Pharma (REGN), is 'Incrementally Positive'

Piper Sandler analyst Christopher Raymond reiterated an Overweight rating and $435.00 price target on Regeneron Pharma (NASDAQ: REGN)

The analyst comments "Incrementally positive on REGN shares after learning that ASRS issued a member communication entitled Beovu Update last night that we think meaningfully... More

Regeneron (REGN) Climbs Following Three Analyst Updates

Regeneron (NASDAQ: REGN) gained Tuesday after it was upgraded to Outperform at Bernstein and Evercore ISI and Buy at Jefferies. Shares climbed 4.5%.

Bernstein Upgrades Regeneron Pharma (REGN) to Outperform

Bernstein upgraded Regeneron Pharma (NASDAQ: REGN) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $432.27 yesterday.

Jefferies Upgrades Regeneron Pharma (REGN) to Buy

Jefferies analyst Biren Amin upgraded Regeneron Pharma (NASDAQ: REGN) from Hold to Buy with a price target of $492.00.

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $425.38 yesterday.

Evercore ISI Upgrades Regeneron Pharma (REGN) to Outperform 'as Beovu Stumble Looks Real'

Evercore ISI analyst Dr. Josh Schimmer upgraded Regeneron Pharma (NASDAQ: REGN) from In Line to Outperform.

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $403.15 yesterday.

Regeneron (REGN) Trades at High, Up 2.8%

Regeneron (NASDAQ: REGN) Trades at High, Up 2.8%